We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Charles B. Nguyen,

Medical Oncologist

Biography photo
Location
City of Hope Orange County Lennar Foundation Cancer Center
1000 Five Point
Irvine, CA 92618
Education
Medical school:
Board Certifications
  • 2024, American Board of Internal Medicine, Oncology
Degrees
  • 2018, Doctor of Medicine, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma
Fellowship
  • 2021-2024, Hematology/Oncology, University of Michigan, Ann Arbor, Michigan
Residency
  • 2018-2021, Internal Medicine, Baylor College of Medicine, Houston, Texas
Professional Experience
  • 2024-present, Assistant Clinical Professor, City of Hope Orange County; Irvine, California
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
About Me

Charles B. Nguyen, M.D. is a nationally recognized medical oncologist with interests in clinical trials, clinicogenomics, and genitourinary cancers. Dr. Nguyen’s clinical trial work includes the phase 2 FORTUNE study in non-clear cell kidney cancer. He has published widely in peer-reviewed journals such as the Journal of Clinical Oncology Precision Oncology and Clinical Cancer Research. He has also presented his work at national conferences such as ASCO.

Dr. Nguyen most recently completed a hematology/oncology fellowship at the University of Michigan in Ann Arbor. Prior to this, he obtained his medical degree from the University of Oklahoma College of Medicine, followed by an internal medicine residency at Baylor College of Medicine.

Earning extensive honors for his work, Dr. Nguyen was selected for the 2022 ASCO/AACR Methods in Clinical Cancer Research workshop and received the V.A. Outstanding Graduating Resident in Inpatient Medicine award. Additionally, he was awarded the Professional Educator Appreciation and Recognition (PEAR) Award and membership in the Gold Humanism Honor Society. Dr. Nguyen is fluent in Vietnamese.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.